OpenAlex
PricingAboutJobs
Log inGet started
Work

AL amyloidosis: a real-world experience with CAR T-cell therapy

HTML PDF

Year: 2025
Type: article
Source: Blood Advances
DOI: 10.1182/bloodadvances.2025017488
Authors: Melinda S. Y. Tan, Rahma Warsame, Ricardo Parrondo, Eli Muchtar, Taxiarchis Kourelis, Francis Buadi, Wilson Gonsalves, Joselle Cook, Prashant Kapoor, Suzanne Hayman, David Dingli, Moritz Binder, Nelson Leung, Vivek Roy, Taimur Sher, J. Erin Wiedmeier-Nutor, Saurabh Chhabra, Rafael Fonseca, Nadine Abdallah, S. Vincent Rajkumar, Shaji K. Kumar, Morie Gertz, Yi Lin, Angela Dispenzieri
Institutions: Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic Hospital, Mayo Clinic in Arizona
Language: English

Topic: Amyloidosis: Diagnosis, Treatment, Outcomes
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
SDG: Good health and well-being

Open Access status: gold
Estimated APC paid: $3,800

Funders: Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Celgene, Karyopharm Therapeutics, Regeneron Pharmaceuticals, Prothena, bluebird bio, BeiGene, Apellis Pharmaceuticals, Ascentage Pharma, Swedish Orphan Biovitrum, Genentech, Pharmacyclics, Legend Biotech
OpenAlex ID: W4415237828
FWCI: 1.515
Cites: 14
Cited by: 6
Related to:
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms